Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Am J Cardiol. 2023 Apr 1;196:89–98. doi: 10.1016/j.amjcard.2023.03.002

Figure 4. Trends of the counts of new prescriptions for GLP-1 RAs and SGLT-2i during 2019–2020.

Figure 4.

Data represent number of new prescriptions for GLP-1 RAs and SGLT-2i per 10k eligible individuals during the study period from 2019 through 2020. Abbreviations: GLP-1; glucagon-like peptide-1 receptor agonist; SGLT-2, sodium glucose cotransporter 2 inhibitor.